{
    "organizations": [],
    "uuid": "f2c74657e9ab8333d8a4d5b85bc2e95a65697e02",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-shire-says-granted-orphan-drug-sta/brief-shire-says-granted-orphan-drug-status-for-crohns-disease-treatment-for-children-idUSFWN1Q30TS",
    "ord_in_thread": 0,
    "title": "Shire Says Granted Orphan Drug Status For Crohn's Disease Treatment For Children",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 13 (Reuters) - Shire Plc:\n* SHIRE - U.S. FDA GRANTS ORPHAN DRUG DESIGNATION FOR INVESTIGATIONAL SHP647 FOR TREATMENT OF PEDIATRIC PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHNâ€˜S DISEASE\n* SHIRE - HEALTH CANADA GRANTS PRIORITY REVIEW FOR INVESTIGATIONAL LANADELUMAB FOR PREVENTION OF ANGIOEDEMA ATTACKS IN OLDER PATIENTS WITH HEREDITARY ANGIOEDEMA\n* SHIRE PLC - PEDIATRIC STUDY PLANS WITH SHP647 ARE CURRENTLY UNDER DISCUSSION WITH HEALTH AUTHORITIES\n* SHIRE PLC - HEALTH CANADA REVIEW OF NDS UNDER PRIORITY REVIEW IS EXPECTED TO BE COMPLETED IN SECOND HALF OF 2018 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-13T20:08:00.000+02:00",
    "crawled": "2018-02-14T12:46:09.007+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "shire",
        "plc",
        "shire",
        "fda",
        "grant",
        "orphan",
        "drug",
        "designation",
        "investigational",
        "shp647",
        "treatment",
        "pediatric",
        "patient",
        "moderately",
        "severely",
        "active",
        "crohn",
        "disease",
        "shire",
        "health",
        "canada",
        "grant",
        "priority",
        "review",
        "investigational",
        "lanadelumab",
        "prevention",
        "angioedema",
        "attack",
        "older",
        "patient",
        "hereditary",
        "angioedema",
        "shire",
        "plc",
        "pediatric",
        "study",
        "plan",
        "shp647",
        "currently",
        "discussion",
        "health",
        "authority",
        "shire",
        "plc",
        "health",
        "canada",
        "review",
        "nd",
        "priority",
        "review",
        "expected",
        "completed",
        "second",
        "half",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}